The Latest Breaking News from HIV

Christian organizations helped create Pepfar, credited with preventing 25m early deaths, particularly in Africa

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....

Yearly doses could reduce barriers people face to taking preventative HIV medication, researchers said.

The first state memorial for a queer advocate has been held for David Polson AM, who participated in a record number of medical trials after contracting HIV.

Federal datasets began disappearing from public view on Jan. 31, 2025, in response to executive orders from President Donald Trump. Among those were the Centers for Disease Control and Prevention’s Youth Risk Behavior Survey, which asks respondents about their gender identity and sexual orientation and tracks behaviors like smoking and…

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s Wolf Prize, a major Israeli award in the arts and sciences

Enormous progress has been made in tackling the global HIV epidemics over the past two decades. The number of people dying from HIV-related causes has fallen by 51% since 2010; and the number of annual new infections has fallen from 2.1 million new infections in 2010 to 1.3 million in…

Experts warn that the tiny marks on toilet paper in public restrooms might be left by substance users wiping and stabbing their needles into them. Folks are absolutely horrified! The post New Fear Unlocked As Experts Warn About Hidden Needle Marks In Public Restrooms Toilet Paper first appeared on Bored…

Stigma, lack of treatment and disproportionate rise of the disease in women draws comparisons with HIV epidemic

NGOs warn that at least two million people worldwide will be affected by the cancellation of US grants. In Kenya, access to HIV pre-exposure prophylaxis and community-led surveillance programmes has already come to a halt. Approximately three percent of the population is HIV positive and is now facing a shortage…

The US President’s Emergency Plan for AIDS Relief has been a cornerstone of global HIV/Aids prevention, care and treatment for over two decades. Pepfar has enjoyed broad bipartisan support in the US, but its future is now uncertain. Public health scholars Eric A. Friedman, Sarah A. Wetter and Lawrence O.…